Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Dexamethasone for PDPH and PONV in C-Section
NCT05202574Phase 2Unknown
- Sponsor
- Minia University
- Start
- Sep 2021
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ondansetron and dexamethasone in post-dural puncture headache (PDPH) and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Minia University. Primary endpoint: Incidence of Post-Dural Puncture Headache. Status: unknown.
02
Drugs
ondansetrondexamethasone
03
Conditions
post-dural puncture headache (PDPH)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05202574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05202574.